04 Sep 2019
A topical solution for superficial basal cell carcinomas
By Staff Writer
Nonmelanoma skin cancers are the most common malignancies in the global white population, with Basal Cell Carcinomas (BCCs) accounting for up to 80 percent of cases1. However, Aldara cream from Innova Pharma has shown efficacy in treating superficial BCC tumours. Sun exposure BCCs are abnormal, uncontrolled growths or lesions that arise in the skin’s basal...
